Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Go back to Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences (FBRX) Misses Q2 EPS by 4c

August 15, 2022 4:38 PM EDT

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

... More